AMELIA CLARK: Open Payments
NPI 1073244596 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 3 payments from 3 companies in 2025. Trend: 2023 $848 · 2024 $128 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $123 |
| Edwards Lifesciences Corporation | 1 | $69 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: DUPIXENT, SAPIEN 3 Ultra RESILIA, LEQVIO.
Industry payments across MT — which companies pay providers there.
